These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12522449)

  • 1. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
    Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
    Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
    Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
    Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
    Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.
    Ishida T; Utsunomiya A; Jo T; Yamamoto K; Kato K; Yoshida S; Takemoto S; Suzushima H; Kobayashi Y; Imaizumi Y; Yoshimura K; Kawamura K; Takahashi T; Tobinai K; Ueda R
    Cancer Sci; 2017 Oct; 108(10):2022-2029. PubMed ID: 28776876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate radiation dose for symptomatic relief and local control in patients with adult T cell leukemia/lymphoma.
    Maemoto H; Ariga T; Nakachi S; Toita T; Hashimoto S; Heianna J; Shiina H; Kusada T; Makino W; Kakinohana Y; Miyagi T; Yamamoto Y; Morishima S; Masuzaki H; Murayama S
    J Radiat Res; 2019 Jan; 60(1):98-108. PubMed ID: 30124892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.
    Ramos JC; Ruiz P; Ratner L; Reis IM; Brites C; Pedroso C; Byrne GE; Toomey NL; Andela V; Harhaj EW; Lossos IS; Harrington WJ
    Blood; 2007 Apr; 109(7):3060-8. PubMed ID: 17138822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.
    Khouri R; Silva-Santos G; Dierckx T; Menezes SM; Decanine D; Theys K; Silva AC; Farré L; Bittencourt A; Mangino M; Roederer M; Vandamme AM; Van Weyenbergh J
    Oncoimmunology; 2018; 7(5):e1426423. PubMed ID: 29721391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
    Bazarbachi A; Hermine O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
    Gill PS; Harrington W; Kaplan MH; Ribeiro RC; Bennett JM; Liebman HA; Bernstein-Singer M; Espina BM; Cabral L; Allen S
    N Engl J Med; 1995 Jun; 332(26):1744-8. PubMed ID: 7760890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).
    Shimoyama M
    Br J Haematol; 1991 Nov; 79(3):428-37. PubMed ID: 1751370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
    Tsukasaki K; Utsunomiya A; Fukuda H; Shibata T; Fukushima T; Takatsuka Y; Ikeda S; Masuda M; Nagoshi H; Ueda R; Tamura K; Sano M; Momita S; Yamaguchi K; Kawano F; Hanada S; Tobinai K; Shimoyama M; Hotta T; Tomonaga M;
    J Clin Oncol; 2007 Dec; 25(34):5458-64. PubMed ID: 17968021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
    Hermine O; Dombret H; Poupon J; Arnulf B; Lefrère F; Rousselot P; Damaj G; Delarue R; Fermand JP; Brouet JC; Degos L; Varet B; de Thé H; Bazarbachi A
    Hematol J; 2004; 5(2):130-4. PubMed ID: 15048063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
    Sharma K; Janik JE; O'Mahony D; Stewart D; Pittaluga S; Stetler-Stevenson M; Jaffe ES; Raffeld M; Fleisher TA; Lee CC; Steinberg SM; Waldmann TA; Morris JC
    Clin Cancer Res; 2017 Jan; 23(1):35-42. PubMed ID: 27486175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
    Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
    Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.
    Ratner L; Harrington W; Feng X; Grant C; Jacobson S; Noy A; Sparano J; Lee J; Ambinder R; Campbell N; Lairmore M;
    PLoS One; 2009; 4(2):e4420. PubMed ID: 19204798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
    Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
    Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 uses a specific tRNA
    Syu YC; Hatterschide J; Budding CR; Tang Y; Musier-Forsyth K
    RNA; 2024 Jul; 30(8):967-976. PubMed ID: 38684316
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.